of all scientific publications of Italian biotechnology firms over the period 1990 to may 2006 and we provide evidence on …

The impact of patent protection on biomedical innovation has been a controversial issue. Although a "medical anti … difficult to predict the impact of patenting on biomedical innovation in developing and least developed countries. This paper … develops a framework of analysis for the impact of patent rights on biomedical innovation in "technology follower" developing …

). This paper aims to fill some of the gaps in our knowledge of biotechnology and innovation processes in New Zealand. It is …The New Zealand Government has indicated a strong interest in fostering innovation and aims to concentrate on selected … areas where New Zealand may be able to develop a new comparative advantage. One such area is biotechnology, which would …

) Entrepreneurship distributed in systems of innovation, 3) Entrepreneurs changing selection criteria, and 4) Rationality vs. uncertainty …

European countries. As a whole, Europe is lagging behind in its ability to generate, organise, and sustain innovation processes … position of the US as a locus of innovation in pharmaceuticals has increased over the past decade compared to Europe. All in …

the 1990s. This enabled us to characterise several features of the innovation process in pharmaceuticals, particularly the … firms - the so-called New Biotechnology Firms (NBFs). Our results can be summarised as follows: a)The NBFs are largely an …

Innovation is becoming a fundamental tool of competitiveness of firms and economies. It is especially relevant in … research intensive branches. Chemical industry belongs to one of the most innovative branches in Hungary. As innovation … innovation by minimizing the costs and risks in the process. With the increasing number of collaborations the types and modes of …